"Mass Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of a medication to at-risk individuals in a population without individual diagnosis. It is often used in order to treat, control, and/or prevent spread of often endemic DISEASE OUTBREAKS such as NEGLECTED DISEASES in high disease burden areas.
| Descriptor ID |
D000074381
|
| MeSH Number(s) |
E02.319.162.575 N06.850.275.500 N06.850.780.200.600
|
| Concept/Terms |
Mass Drug Administration- Mass Drug Administration
- Drug Administration, Mass
- Mass Drug Administrations
- Mass Administration
- Mass Administrations
|
Below are MeSH descriptors whose meaning is more general than "Mass Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "Mass Drug Administration".
This graph shows the total number of publications written about "Mass Drug Administration" by people in this website by year, and whether "Mass Drug Administration" was a major or minor topic of these publications.
Below are the most recent publications written about "Mass Drug Administration" by people in Profiles.
-
Effect of biannual azithromycin on respiratory pathogens among symptomatic children: results from the randomised Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) I trial. BMJ Glob Health. 2025 Feb 10; 10(2).
-
Annual versus biannual azithromycin mass drug administration for the elimination of infectious trachoma in Africa: protocol for a systematic review and meta-analysis using data from individual communities. BMJ Open. 2025 Feb 06; 15(2):e087170.
-
Seroepidemiology of trachoma in a low prevalence region receiving annual mass azithromycin distribution in Maradi, Niger. PLoS Negl Trop Dis. 2024 Dec; 18(12):e0012727.
-
Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A Secondary Analysis of the MORDOR Cluster-Randomized Trial. Clin Infect Dis. 2024 Nov 22; 79(5):1136-1143.
-
Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial. N Engl J Med. 2024 Aug 22; 391(8):699-709.
-
Compliance with tetracycline eye ointment during annual mass drug administration for trachoma control in the Amhara region, Ethiopia. Trop Med Int Health. 2024 Oct; 29(10):869-874.
-
Effectiveness, Safety, and Acceptability of Primaquine Mass Drug Administration in Low-Endemicity Areas in Southern Thailand: Proof-of-Concept Study. JMIR Public Health Surveill. 2024 Jun 26; 10:e51993.
-
Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar. Malar J. 2024 May 08; 23(1):138.
-
Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR). PLoS Med. 2024 May; 21(5):e1004386.
-
District-Level Forecast of Achieving Trachoma Elimination as a Public Health Problem By 2030: An Ensemble Modelling Approach. Clin Infect Dis. 2024 Apr 25; 78(Supplement_2):S101-S107.